Trial intelligence / Profile preview

Preoperative betamethasone acetate before cataract surgery for dry eye control and visual acuity

IRCT2017103037105N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of betamethasone in cataract, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Dry eye control after cataract surgery and Visual acuity after cataract surgery. Started Nov 2016; status: completed.

02

Drugs

betamethasone
03

Conditions

cataract

Beyond the preview

Go deeper on IRCT2017103037105N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017103037105N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call